NCT00164151已完成3 期
A Comparison of the Efficacy and Safety of Two Bowel Preparations: HalfLytely® (2L NuLYTELY and 20 mg Bisacodyl), and Visicol™ Prior To Colonoscopy.
Braintree Laboratories1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2001年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Bowel preparation success: preparation rated as "good" or "excellent" by the blinded investigator.
研究概览
简要总结
The objective of this study is to determine the efficacy and safety of HalfLytely as compared to Visicol as bowel preparations before colonoscopic examination.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female outpatients who are undergoing colonoscopy for routinely accepted indications, Evaluation of BE results, GI bleeding, Anemia of unknown etiology, Neoplastic disease surveillance, Endosonography, Inflammatory bowel disease (except as noted below), Unknown diarrhea etiology, Polypectomy, Laser therapy, Foreign body removal and decompression (except as noted below).
- •18 years of age or older.
- •Otherwise in good health, as determined by physical exam and medical history.
- •If female, and of child-bearing potential, is using an acceptable form of birth control (hormonal birth control, IUD, double-barrier method, or vasectomized spouse).
- •Subjects with electrolyte abnormalities such as hypernatremia, hyperphosphatemia, hypokalemia, or hypocalcemia must have them corrected prior to study participation.
- •Subject has read and signed the written informed consent document prior to study participation.
排除标准
- •Subjects with known or suspected bowel perforation or obstruction, severe inflammatory bowel disease, ileus, acute alimentary tract surgery, significant gastroparesis or gastric outlet obstruction, appendicitis, gastric retention, toxic colitis, toxic megacolon, or massive and/or abnormal rectal bleeding.
- •Subjects with impaired consciousness that predisposes them to pulmonary aspiration.
- •Subjects with uncontrolled cardiovascular disease.
- •Subjects with congestive heart failure.
- •Subjects with unstable angina pectoris.
- •Subjects with ascites.
- •Subjects with renal insufficiency.
- •Subjects who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures.
- •Subjects who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days.
- •Subjects who are pregnant or lactating.
- •Subjects who are allergic to polyethyleneglycol.
- •Subjects who are allergic to sodium phosphate salts.
- •Subjects who are currently taking, or plan to take, other sodium phosphate- containing products, such as enemas or non-prescription liquid purgatives.
- •Subjects with pre-existing electrolyte disturbances, such as dehydration, or those secondary to the use of diuretics.
- •Subjects who are taking drugs that may affect electrolyte levels.
- •Subjects receiving non-study laxatives, antacids and prokinetic agents during the study.
结局指标
主要结局
Bowel preparation success: preparation rated as "good" or "excellent" by the blinded investigator.
次要结局
- Safety: review of preparation symptoms, adverse events and laboratory testing.
- Patient acceptance
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Comparison of the effectiveness and safety of two different starting dosages of cortisone, compared to each other and to placebo, in early active rheumatoid arthritisEUCTR2012-004074-25-DERuhr-Universität Bochum450
已完成
不适用
A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for MyopiaMyopiaAstigmatismNCT00365677Bausch & Lomb Incorporated127
已完成
不适用
The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)Herpes Simplex KeratitisNCT00357812University of Ulster50
已完成
不适用
Femoral Central Venous Access Comparison of 2 MethodsChildNCT02318940University of Chile99
已完成
不适用
The Comparison of Two Crosslinked Hyaluronate for the Treatment of Osteoarthritis PainOsteoarthritis, KneeNCT04000204SciVision Biotech Inc.142